A case of herpes zoster developing after COVID-19 vaccine and recurring after COVID-19 infection in the same dermatome

被引：0
作者：
Kulakli, Sevgi [1 ]
Oguz, Isil Deniz [1 ]
Aksan, Burak [1 ]
机构：
[1] Giresun Univ, Dept Dermatol, Fac Med, Giresun, Turkiye
来源：
TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY | 2023年 / 57卷 / 03期
关键词：
COVID-19; vaccine; herpes zoster;
D O I：
10.4274/turkderm.galenos.2023.91298
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Coronavirus disease-2019 (COVID-19) is an ongoing infectious respiratory disease recognized worldwide as a pandemic, and it can affect many organs and systems, including the skin. Various cutaneous manifestations, including reactivation of varicella-zoster virus related to COVID-19 and COVID-19 vaccination have been reported. We would like to present a 46-year-old female, who developed herpes zoster (HZ) in the right C3 dermatome after m-RNA COVID-19 vaccine and was admitted to our clinic with recurrent HZ in the same dermatome following COVID-19 infection, two months after the vaccination.
引用
收藏
页码：127 / 129
页数：3
相关论文
共 25 条
  • [1] Herpes zoster and COVID-19 infection: a coincidence or a causal relationship?
    Algaadi, Salim Ali
    [J]. INFECTION, 2022, 50 (02) : 289 - 293
  • [2] Can COVID-19 Increase the Risk of Herpes Zoster? A Narrative Review
    Diez-Domingo, Javier
    Parikh, Raunak
    Bhavsar, Amit B.
    Cisneros, Elisa
    McCormick, Natalia
    Lecrenier, Nicolas
    [J]. DERMATOLOGY AND THERAPY, 2021, 11 (04) : 1119 - 1126
  • [3] Herpes zoster emergence following mRNA COVID-19 vaccine
    Eid, Edward
    Abdullah, Lina
    Kurban, Mazen
    Abbas, Ossama
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (09) : 5231 - 5232
  • [4] Increased number of Herpes Zoster cases in Brazil related to the COVID-19 pandemic
    Fernandes Maia, Celia Marcia
    Marques, Nelson Pereira
    Gomes de Lucena, Edson Hilan
    de Rezende, Luiz Fernando
    Barbosa Martelli, Daniella R.
    Martelli-Junior, Hercilio
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 104 : 732 - 733
  • [5] Report of Three Cases of Herpes Zoster During Treatment with Natalizumab
    Fragoso, Yara Dadalti
    Bidin Brooks, Joseph Bruno
    Gomes, Sidney
    Meneses de Oliveira, Francisco Tomaz
    da Gama, Paulo Diniz
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2013, 19 (04) : 280 - 281
  • [6] Varicella zoster virus infection
    Gershon, Anne A.
    Breuer, Judith
    Cohen, Jeffrey I.
    Cohrs, Randall J.
    Gershon, Michael D.
    Gilden, Don
    Grose, Charles
    Hambleton, Sophie
    Kennedy, Peter G. E.
    Oxman, Michael N.
    Seward, Jane F.
    Yamanishi, Koichi
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [7] Advances in the understanding of the pathogenesis and epidemiology of herpes zoster
    Gershon, Anne A.
    Gershon, Michael D.
    Breuer, Judith
    Levin, Myron J.
    Oaklander, Anne Louise
    Griffiths, Paul D.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2010, 48 : S2 - S7
  • [8] Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring
    Khoy, Kathy
    Mariotte, Delphine
    Defer, Gilles
    Petit, Gautier
    Toutirais, Olivier
    Le Mauff, Brigitte
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [9] Recurrence Rate of Herpes Zoster and Its Risk Factors: a Population-based Cohort Study
    Kim, You Jeong
    Lee, Chang Nam
    Lee, Mi So
    Lee, Ji Hyun
    Lee, Jun Young
    Han, Kyungdo
    Park, Young Min
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2019, 34 (02)
  • [10] Llado Inigo, 2021, JAAD Case Rep, V15, P62, DOI 10.1016/j.jdcr.2021.07.011
123